raPROVE-IT–AtvTNT–Atv10TNT–Atv80ClearCardiovascularBenefitsofstatinsforLipid-LoweringTherapyIDEAL-SimIDEAL-AtvASCOT-PLMEGA-RxMEGA-PlJUPITER-PlJUPITER-Rosu降LDL-C治疗目标值?LDL-C降幅与粥样斑块体积改变阻止斑块进展,需要LDL-C水平至少下降50%虚线为平均水平95%CIsLDL-C改变(%)20151050-5-10-15粥样斑块体积改变,mm3-80-70-60-50-40-30-20-1001020StevenE.al.JAMA.2004;291:1071-1080降LDL-C治疗目标值?LDL-C降幅与粥样斑块体积改变阻止斑块进展,需要LDL-C水平至少下降50%虚线为平均水平95%CIsLDL-C改变(%)20151050-5-10-15粥样斑块体积改变,mm3-80-70-60-50-40-30-20-1001020StevenE.al.JAMA.2004;291:1071-1080阻止斑块进展需要LDL-C水平至少下降50%20,536名高危患者,TC>3.5mmol/L摘自HeartProtectionStudyCollaborativeGroupLancet2002;360:7-22;?MRC/BHFHeartProtectionStudyCollaborativeGroupEurHeartJ1999;20:725-741;?munication.心脏保护研究(HPS)高危患者:冠心病、糖尿病、周围血管疾病、治疗中的高血压冠心病?7,414糖尿病?2,912其它血管疾病?3,1681,9811,0703,991周围血管疾病=6,748中风=3,280总人数=5,963治疗中的高血压患者=8,457